共 10 条
[1]
New doppler echocardiographic applications for the study of diastolic function. Garcia MJ,Thomas JD,K lein AL. Journal of the American College of Cardiology . 1998
[2]
Ventricular expression of natriuretic peptides in Nprl m ice with cardiac hypertrophy and fibrosis. E llmers LJ,Knowles JW,K im HS,et al. American Journal of Physiology Heart and Circulatory Physiology . 2002
[3]
Utility of a rap id Bnatriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. Morrison LK,Harrison A,Krishnaswamy P,et al. Journal of the American College of Cardiology . 2002
[4]
C linical aspects of hypertensive myocardial fibrosis. D iez J,Lopez B,Gonzalez A,et al. Current Opinion in Cardiology . 2001
[5]
Utility of B-natriuretic peptide levels in identifying patientswith ventricular systolic or diastolic dysfunction. Krishnaswamy P,Lubien E,C lopton P,et al. The American Journal of The Medical Sciences . 2001
[6]
The natriuretic peptide fam ily. W ilkinsMR,Redondo J,Brown LA. The Lancet . 1997
[7]
CIRCULATION[P]. MIYAKE TETSUYA;OGAWA TOKUHITO;ASANO MOTOHISA;OKUYAMA KAZUO.日本专利:JPS52144376A,1977-12-01
[8]
Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Lubien E,Demaria A,Krishnaswamy P,et al. Circulation . 2002
[9]
Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. SchillaciG,Pasqualini L,Verdecchia P,et al. Journal of the American College of Cardiology . 2002
[10]
U ltrasonic backscatter and diastolic function in hypertensive patients. Maceira AM,Barba J,Beloqui O,et al. Journal of Hypertension . 2002